127 related articles for article (PubMed ID: 1360888)
1. Allele loss on chromosome 11p is associated with poor survival in ovarian cancer.
Eccles DM; Gruber L; Stewart M; Steel CM; Leonard RC
Dis Markers; 1992; 10(2):95-9. PubMed ID: 1360888
[TBL] [Abstract][Full Text] [Related]
2. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
4. A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
Lu KH; Weitzel JN; Kodali S; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1997 Feb; 57(3):387-90. PubMed ID: 9012461
[TBL] [Abstract][Full Text] [Related]
5. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
6. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
7. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
10. Allele loss from chromosome 17 in ovarian cancer.
Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
[TBL] [Abstract][Full Text] [Related]
11. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer.
Purdie CA; Piris J; Bird CC; Wyllie AH
J Pathol; 1995 Mar; 175(3):297-302. PubMed ID: 7745498
[TBL] [Abstract][Full Text] [Related]
12. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.
Knowles MA; Shaw ME; Proctor AJ
Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582
[TBL] [Abstract][Full Text] [Related]
13. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis.
Watson RH; Neville PJ; Roy WJ; Hitchcock A; Campbell IG
Oncogene; 1998 Jul; 17(2):207-12. PubMed ID: 9674705
[TBL] [Abstract][Full Text] [Related]
17. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor.
Vandamme B; Lissens W; Amfo K; De Sutter P; Bourgain C; Vamos E; De Grève J
Cancer Res; 1992 Dec; 52(23):6646-52. PubMed ID: 1423308
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
[TBL] [Abstract][Full Text] [Related]
19. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
[TBL] [Abstract][Full Text] [Related]
20. Loss of genes on the short arm of chromosome 11 in human lung carcinomas.
Shiraishi M; Morinaga S; Noguchi M; Shimosato Y; Sekiya T
Jpn J Cancer Res; 1987 Dec; 78(12):1302-8. PubMed ID: 2892820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
